Opaleye Management Inc. Zymeworks Inc. Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$33.67 - $40.0 $4.48 Million - $5.32 Million	-133,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$24.28 - $49.8 $1.02 Million - $2.09 Million	-42,000 Reduced 24.0%	133,000 $4.72 Million
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $124,200 - $227,300	5,000 Added 2.94%	175,000 $7.96 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $22.49 $1.73 Million - $2.59 Million	115,000 Added 209.09%	170,000 $3.74 Million
Q1 2019 May 15, 2019	SELL	$14.02 - $16.74 $701,000 - $836,999	-50,000 Reduced 47.62%	55,000 $890,000
Q4 2018 Feb 14, 2019	BUY	$10.95 - $15.44 $1.15 Million - $1.62 Million	105,000 New	105,000 $1.54 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $856M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.